Market Overview

Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Related TRIB
Worst Performing Industries For November 3, 2014
Trinity Biotech Announces Quarter 3 Financial Results And Temporary Suspension Of Meritas Troponin Trials
Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.32%. Trinity Biotech's ROE for the same period is 10.69%.

The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 17.59%. Meridian Bioscience's operating margin for the same period is 27.44%.

The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 13.31%. IDEXX Laboratories' revenue for the same period is $1.27 billion.

The trailing-twelve-month profit margin at Neogen (NASDAQ: NEOG) is 12.23%. Neogen's PEG ratio is 1.93.

Posted-In: Diagnostic Substances Industry Highest Profit Margin NASDAQ StocksEarnings News Pre-Market Outlook Markets

 

Related Articles (IDXX + NEOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters